Folixate
Folixate is an FDA drug label for the active ingredient FOLATE, VITAMIN D3 manufactured by PureTek Corporation administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231205.
Generic: FOLATE, VITAMIN D3
Manufacturer: PureTek Corporation
Product Type: HUMAN PRESCRIPTION DRUG
Route: ORAL
Dosage Form:
NDC: 59088-301
Application:
Effective: 20231205
Indications & Usage
INDICATIONS AND USAGE Folixate ™ is indicated for dietary management of patients with unique nutritional needs requiring increased folate level and Vitamin D supplementation. Folixate™ can be taken by women of childbearing age, pregnant women, and lactating and nonlactating mothers.
Dosage & Administration
DOSAGE AND ADMINISTRATION Take one tablet daily or as directed by a licensed healthcare practitioner.
Contraindications
CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Folixate ™ is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of Vitamin D, and hypervitaminosis D.
Warnings
Not available.
Adverse Reactions
ADVERSE REACTIONS Allergic sensitization has been reported following both oral and parenteral administration of folate. You should call your doctor for medical advice about serious adverse events. To report adverse side effects or to obtain product information, contact PureTek Corporation, at 1-877-921-7873.
More from same ingredient
No related products.